Lantheus Holdings, Inc. (LNTH) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 697.00K USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 2.41B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $697.00K | (m) | (m) | (m) | $2.41B | (m) |
| 2026-03-31 | (m) | (m) | $803.00K | (m) | (m) | (m) | $2.35B | (m) |
| 2025-12-31 | (m) | (m) | $738.00K | (m) | (m) | (m) | $2.23B | (m) |
| 2025-09-30 | (m) | (m) | $871.00K | (m) | (m) | (m) | $2.28B | (m) |
| 2025-06-30 | (m) | (m) | $796.00K | (m) | (m) | (m) | $2.12B | (m) |
| 2025-03-31 | (m) | (m) | $747.00K | (m) | (m) | (m) | $2.06B | (m) |
| 2024-12-31 | (m) | (m) | $974.00K | (m) | (m) | (m) | $1.98B | (m) |
| 2024-09-30 | (m) | (m) | $564.71M | (m) | (m) | (m) | $2.05B | (m) |
| 2024-06-30 | (m) | (m) | $868.00K | (m) | (m) | (m) | $1.94B | (m) |
| 2024-03-31 | (m) | (m) | $734.00K | (m) | (m) | (m) | $1.83B | (m) |
| 2023-12-31 | (m) | (m) | $823.00K | (m) | (m) | (m) | $1.65B | (m) |
| 2023-09-30 | (m) | (m) | $703.00K | (m) | (m) | (m) | $1.52B | (m) |
| 2023-06-30 | (m) | (m) | $384.00K | (m) | (m) | (m) | $1.34B | (m) |
| 2023-03-31 | (m) | (m) | $422.00K | (m) | (m) | (m) | $1.35B | (m) |
| 2022-12-31 | (m) | (m) | $354.00K | $557.71M | (m) | (m) | $1.32B | (m) |
| 2022-09-30 | (m) | (m) | $15.37M | (m) | (m) | (m) | $1.10B | (m) |
| 2022-06-30 | (m) | (m) | $14.06M | (m) | (m) | (m) | $1.01B | (m) |
| 2022-03-31 | (m) | (m) | $12.88M | (m) | (m) | (m) | $933.17M | (m) |
| 2021-12-31 | (m) | (m) | $11.64M | $163.12M | (m) | (m) | $863.78M | (m) |
| 2021-09-30 | (m) | (m) | $10.36M | (m) | (m) | (m) | $847.82M | (m) |
| 2021-06-30 | (m) | (m) | $10.37M | (m) | (m) | (m) | $857.80M | (m) |
| 2021-03-31 | (m) | (m) | $10.25M | $171.47M | (m) | (m) | $843.45M | (m) |
| 2020-12-31 | (m) | (m) | $20.70M | $197.70M | (m) | (m) | $869.82M | (m) |
| 2020-09-30 | (m) | (m) | $18.14M | $204.67M | (m) | (m) | $879.59M | (m) |
| 2020-06-30 | (m) | (m) | $17.14M | $210.01M | (m) | (m) | $879.70M | (m) |
| 2020-03-31 | (m) | (m) | $10.14M | $181.49M | (m) | (m) | $404.13M | (m) |
| 2019-12-31 | (m) | (m) | $10.14M | $183.93M | (m) | (m) | $405.92M | (m) |
| 2019-09-30 | (m) | (m) | $10.17M | $186.37M | (m) | (m) | $402.41M | (m) |
| 2019-06-30 | (m) | (m) | $10.14M | $188.71M | (m) | (m) | $390.25M | (m) |
| 2019-03-31 | (m) | (m) | $2.85M | $263.29M | (m) | (m) | $443.91M | (m) |
| 2018-12-31 | (m) | (m) | $2.75M | $263.71M | (m) | (m) | $439.83M | (m) |
| 2018-09-30 | (m) | (m) | $2.75M | $264.13M | (m) | (m) | $424.82M | (m) |
| 2018-06-30 | (m) | (m) | $2.75M | $264.55M | (m) | (m) | $401.80M | (m) |
| 2018-03-31 | (m) | (m) | $2.75M | $264.97M | (m) | (m) | $392.59M | (m) |
| 2017-12-31 | (m) | (m) | $2.75M | $265.39M | (m) | (m) | $383.86M | (m) |
| 2017-09-30 | (m) | (m) | $2.75M | $265.52M | (m) | (m) | $281.02M | (m) |
| 2017-06-30 | (m) | (m) | $2.75M | $265.93M | (m) | (m) | $267.88M | (m) |
| 2017-03-31 | (m) | (m) | $2.75M | $266.33M | (m) | (m) | $249.56M | (m) |
| 2016-12-31 | (m) | (m) | $3.65M | $274.46M | (m) | (m) | $255.90M | (m) |
| 2016-09-30 | (m) | (m) | $3.65M | $294.58M | (m) | (m) | $254.97M | (m) |
| 2016-06-30 | (m) | (m) | $3.65M | $348.84M | (m) | (m) | $259.27M | (m) |
| 2016-03-31 | (m) | (m) | $3.65M | $349.35M | (m) | (m) | $249.26M | (m) |
| 2015-12-31 | (m) | (m) | $3.65M | $349.86M | (m) | (m) | $242.38M | (m) |
| 2015-09-30 | (m) | (m) | $3.65M | $350.37M | (m) | (m) | $236.13M | (m) |
| 2015-06-30 | (m) | (m) | $3.65M | $350.93M | (m) | (m) | $233.55M | (m) |
| 2014-12-31 | (m) | (m) | (m) | $392.86M | (m) | (m) | $243.15M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |